Month: October 2014

CICATS Director Dr. Cato Laurencin recognized for work in Regenerative Engineering

Dr. Cato Laurencin
UConn Health’s Dr. Cato Laurencin says regenerative engineering will soon revolutionize how musculoskeletal tissue injuries are treated. – Lanny Nagler, UConn Health Center

Original article written by Ray Hardman for WNPR8:48 AM | TUE, OCTOBER 7, 2014

CICATS Director Dr. Cato Laurencin, has won the National Institutes of Health (NIH) Director’s Pioneer Award for work in Regenerative Engineering.

The Director’s Pioneer Awards are given by the NIH to scientists whose work has the potential to produce “unusually high impact” in solving important biomedical or behavioral health problems. One of this year’s winners is Dr. Cato Laurencin, professor of Orthopaedic Surgery, and founding director of UConn Health’s Institute for Regenerative Engineering. He was awarded $4 million to continue his work in the field.

Read and listen to more of this article on

Drug Discovery and Inflammation Symposium

The Connecticut Institute for Clinical and Translational Science (CICATS) at UConn Seminar Series:
Drug Discovery and Inflammation Symposium The Drug Discovery and Inflammation Symposium in conjunction with the New England Structure Symposium (NESS) on Structural Biology of Inflammation will bring together scientists and clinicians from academia and industry to provide an overview of current progress in the identification of novel strategies for treatment and prevention of chronic inflammatory disorders.

Symposium Speakers:

  • Lauren Sansing, M.D., Yale University, “Targeting macrophage responses to improve recovery after intracerebral hemorrhage”
  • Alan I. Faden, M.D., University of Maryland School of Medicine, “Chronic Inflammation in Posttraumatic Neurodegeneration and Neuroplasticity: Therapeutic Targets”
  • Laura Silvian, Ph.D., Biogen Idec Inc., “Disrupting nrf2/keap1 protein interaction with non-covalent inhibitors” 
  • Yow-Pin Lim, M.D., Brown Medical School and Prothera Biologics, Inc., “Development of Inter-alpha Inhibitor as a Novel Immunomodulator in Acute Life-Threatening Diseases”
  • Jaques Banchereau, Ph.D., Jackson Laboratory and UConn Health, “The power of genomics to understand inflammatory diseases and identify therapeutic targets”
  • Massimo Gadina Ph.D., NIH/NIAMS, “Novel therapies for autoimmune, inflammatory and malignant diseases: the coming of age of JAK inhibitors”

Host: New Pathways to Drug Discovery CICATS Core Interest Group

Date: Thursday, October 16, 2014

Time: 11:00 p.m. to 6:00 p.m.

Location: Grossman Auditorium, 400 Farmington Ave., Farmington, CT

To R.S.V.P. , please email Dr. Sandra Weller at by Friday, October 10.   Lunch will be provide and there is no cost to attend the symposium.